Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kristoffer M. Moore"'
Autor:
Robin John Shattock, Voahangy Andrianaivoarimanana, Paul F. McKay, Lovasoa Nomena Randriantseheno, Valarmathy Murugaiah, K. Samnuan, Paul Rogers, John S. Tregoning, Minoarisoa Rajerison, Kristoffer M. Moore, Thomas Robert Laws, E. Diane Williamson
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Mice were immunized with a combination of self-amplifying (sa) RNA constructs for the F1 and V antigens of Yersinia pestis at a dose level of 1 μg or 5 μg or with the respective protein sub-units as a reference vaccine. The immunization of outbred
Externí odkaz:
https://doaj.org/article/192ac3598338412086dec12fd8774ddc
Autor:
Barry D. Moore, Clair Macleod, Lisa Henning, Robert Krile, Ying-Liang Chou, Thomas R. Laws, Wendy A. Butcher, Kristoffer M. Moore, Nicola J. Walker, Ethel Diane Williamson, Darrell R. Galloway
Publikováno v:
Vaccines, Vol 10, Iss 2, p 145 (2022)
Background: The need for an updated plague vaccine is highlighted by outbreaks in endemic regions together with the pandemic potential of this disease. There is no easily available, approved vaccine. Methods: Here we have used a murine model of pneum
Externí odkaz:
https://doaj.org/article/d5730a07d23a4f4b930a89a083d222fe
Autor:
Barry D. Moore, Clair Macleod, Lisa Henning, Robert Krile, Ying-Liang Chou, Thomas R. Laws, Wendy A. Butcher, Kristoffer M. Moore, Nicola J. Walker, Ethel Diane Williamson, Darrell R. Galloway
Publikováno v:
Vaccines; Volume 10; Issue 2; Pages: 145
Background: The need for an updated plague vaccine is highlighted by outbreaks in endemic regions together with the pandemic potential of this disease. There is no easily available, approved vaccine. Methods: Here we have used a murine model of pneum
Autor:
Voahangy Andrianaivoarimanana, Minoarisoa Rajerison, Steven G Lonsdale, Lovasoa Nomena Randriantseheno, Sarah Kempster, Neil A Almond, Kristoffer M Moore, E. Diane Williamson, Nicola J. Walker
Publikováno v:
Immunother Adv
Summary Two monoclonal antibodies directed to the V antigen of Yersinia pestis have been tested for protective efficacy in a murine model of bubonic plague. Mice were infected with a current clinical isolate from Madagascar, designated Y. pestis 10